论文信息 - CD40-targeted peptide proposed for type 1 diabetes therapy lacks relevant binding affinity to its cognate receptor - 字舞流文

CD40-targeted peptide proposed for type 1 diabetes therapy lacks relevant binding affinity to its cognate receptor

Fa Liu | K. Coppieters | Philippe P. Pagni | M. Herrath | Guangsen Fu | Mauro Lo Conte | R. Yeh | A. Wolf

[1] P. Buchwald,et al. CD40-targeting KGYY15 peptides do not efficiently block the CD40–CD40L interaction , 2019, Diabetologia.

[2] Michael H. Olmstead,et al. CD40-targeted peptide proposed for type 1 diabetes therapy lacks relevant binding affinity to its cognate receptor. Reply to Pagni PP, Wolf A, Lo Conte M et al [letter] , 2019, Diabetologia.

[3] P. Agrawal,et al. In silico approaches for predicting the half-life of natural and modified peptides in blood , 2018, PloS one.

[4] Michael H. Olmstead,et al. A CD40-targeted peptide controls and reverses type 1 diabetes in NOD mice , 2014, Diabetologia.

[5] S. Paik,et al. Crystallographic and Mutational Analysis of the CD40-CD154 Complex and Its Implications for Receptor Activation* , 2011, The Journal of Biological Chemistry.

[6] Y. Hsu,et al. Anti-CD40L Immune Complexes Potently Activate Platelets In Vitro and Cause Thrombosis in FCGR2A Transgenic Mice , 2010, The Journal of Immunology.

[7] M. V. von Herrath,et al. CD40L blockade prevents autoimmune diabetes by induction of bitypic NK/DC regulatory cells. , 2002, Immunity.

[8] R. Tisch,et al. CD40 ligand-CD40 interactions are necessary for the initiation of insulitis and diabetes in nonobese diabetic mice. , 1997, Journal of immunology.

[9] G. A. Jeffrey,et al. An Introduction to Hydrogen Bonding , 1997 .